Clinical Trial Update: DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of DA-EDOCH14-R in poor-prognosis diffuse large B-cell lymphoma; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• DA-EDOCH14-R

Snippet

Sponsor: Hospital Universitario Principe de Asturias | Conditions: Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 2 | Status: UNKNOWN